Efficacy of Mentalization-Based Group Therapy for Adolescents: A Pilot Randomised Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Edinburgh
- Enrollment
- 53
- Locations
- 1
- Primary Endpoint
- Self-harm as measured by the self-harm sub scale of the Risk-taking and Self-harm Inventory for Adolescents (Vrouva et al, 2010)
Study Overview
Brief Summary
This is a prospective parallel group design of group-based Mentalization-Based Therapy for Adolescents (MBT-A) through a pilot randomised controlled trial comparing group-based MBT-A plus treatment as usual (TAU) to TAU alone. As a pilot study, we aim to determine: the effectiveness of our recruitment strategies; compliance with protocol/procedures; trends towards reduced self-harm.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 12 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Self-harm behaviour in the past 6 months
- •In receipt of treatment from local Child and Adolescent Mental Health Services
- •Competent and willing to provide written, informed consent.
Exclusion Criteria
- •Severe learning disability or pervasive developmental disorder
- •Acute psychotic episode
- •Eating disorder in the absence of self-harm.
- •Non-English speaking
- •Current involvement in other ongoing treatment research
Arms & Interventions
MBT therapy plus treatment as usual
Mentalization based group treatment for adolescents plus standard care
Intervention: Mentalization-Based Group Therapy for Adolescents (Other)
Treatment as usual alone
Standard care provided by local Child and Adolescent Mental Health Services
Outcomes
Primary Outcomes
Self-harm as measured by the self-harm sub scale of the Risk-taking and Self-harm Inventory for Adolescents (Vrouva et al, 2010)
Time Frame: 12 weeks
Self-harm and related hospital use as reported in National Health Service patient records
Time Frame: 12 weeks
Secondary Outcomes
No secondary outcomes reported